IMPORTANT INVESTOR ALERT: Lundin Law PC Announces an Investigation of Trinity Biotech plc & Advises Investors with Losses to ...
06 October 2016 - 4:28AM
Business Wire
Lundin Law PC (http://lundinlawpc.com/) announces that it is
investigating claims against Trinity Biotech plc (“Trinity” or the
“Company”) (Nasdaq: TRIB) concerning possible violations of federal
securities laws.
To get more information about this investigation, please contact
Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or via
email at brian@lundinlawpc.com.
The investigation concerns Trinity’s October 4, 2016
announcement that it will withdraw its 510(k) premarket
notification submission for the Meritas Troponin-I Test and Meritas
Point-of-Care Analyzer on the advice of the U.S. Food & Drug
Administration. The Company also stated that it would reduce
spending by nearly 85% and that it would close a Swedish facility,
eliminating 40 jobs. When this information was announced, shares of
Trinity fell in value.
Lundin Law PC was founded by Brian Lundin, a securities
litigator based in Los Angeles dedicated to upholding shareholders’
rights.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161005006246/en/
Lundin Law PCBrian Lundin, Esq.Telephone: 888-713-1033Facsimile:
888-713-1125brian@lundinlawpc.comhttp://lundinlawpc.com/
Trinity Biotech (NASDAQ:TRIB)
Historical Stock Chart
From Apr 2024 to May 2024
Trinity Biotech (NASDAQ:TRIB)
Historical Stock Chart
From May 2023 to May 2024